SHORT MINI-FUTURE - SARTORIUS VZ Share Price

Certificat

DE000VX0U4W4

Delayed Deutsche Boerse AG 12:44:08 21/05/2024 BST
39.11 EUR -0.05% Intraday chart for SHORT MINI-FUTURE - SARTORIUS VZ
Current month+3.52%
1 month+0.28%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/05/24 39.11 -0.05%
20/05/24 39.13 -0.20%
17/05/24 39.21 +2.56%
16/05/24 38.23 +3.86%
15/05/24 36.81 -1.15%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 12:44 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying SARTORIUS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VX0U4W
ISINDE000VX0U4W4
Date issued 23/08/2021
Strike 661.3
Maturity Unlimited
Parity 10 : 1
Emission price 13.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 44.26
Lowest since issue 6.61
Spread 0.03
Spread %0.08%

Company Profile

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Sector
-
More about the company

Ratings for Sartorius AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Sartorius AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
270 EUR
Average target price
326.8 EUR
Spread / Average Target
+21.02%
Consensus